Editor of Patient Care Online.
Respiratory Virus Vaccines: AAFP Board Chair on Patient Eligibility, How to Combat Misinformation this Season
Encouraging patients to reach out with questions may lead more to roll up their sleeves this season, Tochi Iroku-Malize, MD, told Patient Care.
Mediterranean Diet Associated with Improved Cardiometabolic Health in Youth, According to First Meta-Analysis of its Kind
Adherence to Mediterranean diet-based interventions was associated with reductions in BP, triglycerides, total cholesterol, and LDL-C, as well as increases in HDL-C among children and adolescents.
Opioid Use Disorder Treatment in Primary Care: What do Patients Think?
Find key results from a new survey examining Americans' attitudes, beliefs, and knowledge about opioid use disorder treatment in primary care, here.
Disease-Tailored Preventive Intervention Reduces Alcohol Use in High-Risk Youths with Chronic Medical Conditions
Results from secondary analysis suggest future work is needed to extend the prevention intervention to address additional chronic conditions and substance use.
Semaglutide vs Tirzepatide for Weight Loss in Persons with Obesity: Daily Dose
Your daily dose of the clinical news you may have missed.
FDA Declines Approval of High-Dose Naloxone Rescue Medication, OX124 for a Second Time
The FDA requested an additional human factors study and more technical data on the final commercial product.
Three Obesity-Related Comorbidities and Management Guidance for Primary Care
Get details on the relationship between obesity and mental health conditions, chronic pain, and hypertension, here.
Exercise Plus Liraglutide May Preserve Bone Quality during Weight Loss: Daily Dose
Severity of SARS-CoV-2 Reinfection Similar to That of Initial Infection, According to New Findings
Researchers also found that a lower proportion of individuals were diagnosed with long COVID following reinfection than after initial infection.
GLP-1RAs Reduce Risk of Some Obesity-Related Cancers in Patients with T2D: Daily Dose
Respiratory Virus Vaccine Update: AAFP Board Chair Details ACIP 2024-25 Recommendations
Tochi Iroku-Malize, MD, discusses the ACIP's updated recommendations for immunization against COVID-19, influenza, and RSV.
7 Drugs Approved for Primary Care: Q2 2024
ICYMI: A quick look at 7 key drugs FDA-approved in the second quarter for conditions commonly seen in primary care.
Americans Unaware of Opioid Use Disorder Treatment in Primary Care: Daily Dose
Remaining Free of Diabetes for at Least 4 Years Improves Long-Term Health in Persons with Impaired Glucose Tolerance
Long-term risk of death decreased by 26% and risk for vascular complications decreased by 40% in persons who remained diabetes-free for 4 years, according to new data.
FDA Approves Donanemab for Early Symptomatic Alzheimer Disease: Daily Dose
States with Higher COVID-19 Vaccination Rates Saw Reduction in Pediatric Asthma Prevalence
A new study shows that higher vaccination rates were associated with a decrease in the prevalence of parent-reported asthma symptoms in children.
Workplace Sexual Harassment Linked to Higher Risk of Cardiometabolic Diseases: Daily Dose
GLP-1RAs Linked to Decreased Risk of Some Obesity-Related Cancers in Patients with T2D
GLP-1RAs were associated with a significantly reduced risk of obesity-associated cancers including gallbladder cancer, pancreatic cancer, and meningioma.
FDA Approves Ensifentrine for Maintenance Treatment of COPD in Adults: Daily Dose
More Than 60% of US Adults Unaware Primary Care Clinicians Can Prescribe Medications for Opioid Use Disorder
Findings from a national survey also showed that Black respondents were most likely to believe they could not receive medications for OUD at a PCP.
Aspirin Still Used for Primary Prevention among Older Americans Without CVD: Daily Dose
Workplace Sexual Harassment Tied to Higher Risk of CVD, T2D in Men and Women
The risk for developing CVD and T2D was highest among individuals who frequently experienced the behavior in the workplace, according to new study.
Sex Disparities in Long-Term Lipid Management: Daily Dose
CDC Updates COVID-19, Influenza Vaccine Recommendations for 2024-2025 Respiratory Virus Season
Individuals 6 months and older should receive updated COVID-19 and influenza vaccines for the 2024-2025 respiratory virus season, the agency recommended.
Prevalence of Chronic HTN During Pregnancy in US: Daily Dose
SECURE-T2D: Automated Insulin Delivery System Reduced A1c in Adults with Type 2 Diabetes
ADA 2024. Adults started on the Omnipod 5 AID system had an A1c reduction from 8.2% at baseline to 7.4% at 13 weeks, researchers report.
Racial Disparities in Cardiovascular Disease Outcomes: Daily Dose
One-Quarter of Adults with Difficult-to-Control T2D have Hypercortisolism, According to New Data
ADA 2024. Adults using more antihypertensive medications had higher odds for hypercortisolism, according to new data from the CATALYST phase 4 study.
Dapagliflozin Approved for Treatment of T2D in Children: Daily Dose
FLOW Trial: Semaglutide Lowers Risk for Major Kidney Disease, CV Events and Death Regardless of SGLT-2i Use
ADA 2024. Semaglutide benefits were observed for adults with type 2 diabetes and chronic kidney disease whether or not they used SGLT-2 inhibitors, according to an analysis of FLOW trial data.
